CompletedPhase 4ketamine

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

Sponsored by University Medical Center of Southern Nevada

NCT ID
NCT02657031
Target Enrollment
54 participants
Start Date
2016-03-17
Est. Completion
2017-03-21

About This Study

This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.

Conditions Studied

Headache

Interventions

  • Prochlorperazine
  • Ketamine
  • Diphenhydramine
  • Ondansetron
  • Normal Saline

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age 18 to 65 years
* Temperature \< 100.4° F
* Diastolic Blood Pressure \<104 mm Hg
* Normal neurological exam and mormal mental status

Exclusion Criteria:

* Pregnant or breastfeeding.
* Meningeal signs are present
* Acute angle closure glaucoma is suspected.
* Head trauma within the previous two weeks
* Lumbar puncture within the previous two weeks
* Thunderclap onset of the headache
* Weight more than 150 kg or less than 40 kg.
* Known allergy to one of the study drugs.
* History of schizophrenia or bipolar disorder.
* History of intracranial hypertension.
* Is a prisoner
* Patient declined informed consent
* Non-English speaking patient.
* Attending provider excludes patient

Study Locations (1)

University Medical Center of Southern Nevada
Las Vegas, Nevada, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source